Biosortia Microbiomics Company
Biosortia works on new drugs from deep access to the chemistry of the microbiome for immuno-oncology and immunological therapeutics.
Total Funding:
59000000
Headquarters:
Dublin, Ohio, United States
Funding Status:
Seed
Employee Number:
11-50
Estimated Revenue:
$1M to $10M
Last Funding Type:
Series C
Technology:
['BioTech & HealthTech']
Investor Type:
Inquiries@Biosortia.com
Last Funding Date:
2017-10-01
Investors Number:
1.0
Founded Date:
2012-01-01
Industry:
Medical BioTech